Ying Yuan

71PUBLICATIONS
242CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersLarge and complex data theory
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Apr 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

|Apr 22, 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

|Apr 17, 2026
Generalized Pairwise Comparisons in Dose Optimization Oncology Trials: Beyond Safety to Multi-outcome Dose Selection.

|Mar 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Oct 08, 2025
Randomized optimal selection design for dose optimization.

Shuqi Wang, Ying Yuan, Suyu Liu

|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Dosages for First-in-Human Trials.

Hao Zhu, Alex N Phipps, Ying Yuan

Pageof 12

Frequent Collaborators

13 joint publications

Ruitao Lin

6 joint publications

Funda Meric-Bernstam

4 joint publications

Jordi Rodon Ahnert

4 joint publications

Yong Zang